Choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen

Journal of Urology

Volumn 189, Issue 1, 2013, Pages 105-110

  Giovacchini, Giampiero ^a,e   Picchio, Maria ^b,c   Garcia Parra, Rita ^b   Mapelli, Paola ^b   Briganti, Alberto ^b   Montorsi, Francesco ^b   Gianolli, Luigi ^b   Messa, Cristina ^a,c,d  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c CNR   (Italy)

^d SAN GERARDO HOSPITAL   (Italy)

^e Stadtspital Waid ^*  (Switzerland)

Author keywords

positron emission tomography and computed tomography; prostate specific antigen; prostatic neoplasms

Indexed keywords

CHOLINE C 11; PROSTATE SPECIFIC ANTIGEN; CARBON; CHOLINE; DIAGNOSTIC AGENT;

ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SALVAGE THERAPY; AGED; BLOOD; EARLY DIAGNOSIS; MALE; METHODOLOGY; MIDDLE AGED; PROSTATE TUMOR; SCINTISCANNING; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; CARBON RADIOISOTOPES; CHOLINE; EARLY DETECTION OF CANCER; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84870879580     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.09.001     Document Type: Article

References (28)

1. M. Han, A.W. Partin, M. Zahurak Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer J Urol 169 2003 517
2. M. Picchio, C. Messa, C. Landoni Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography J Urol 169 2003 1337
3. B.J. Krause, M. Souvatzoglou, M. Tuncel The detection rate of [(11)C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer Eur J Nucl Med Mol Imaging 35 2008 18
4. G. Giovacchini, M. Picchio, E. Coradeschi Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy Eur J Nucl Med Mol Imaging 37 2010 301
5. G. Giovacchini, M. Picchio, V. Scattoni PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy Eur J Nucl Med Mol Imaging 37 2010 1106
6. P. Castellucci, C. Fuccio, C. Nanni Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy J Nucl Med 50 2009 1394
7. P. Castellucci, C. Fuccio, D. Rubello Is there a role for (11)C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? Eur J Nucl Med Mol Imaging 38 2011 55
8. M. Picchio, A. Briganti, S. Fanti The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer Eur Urol 59 2011 51
9. J.D. Soyka, M.A. Muster, D.T. Schmid Clinical impact of (18)F-choline PET/CT in patients with recurrent prostate cancer Eur J Nucl Med Mol Imaging 39 2012 936
10. N. Mottet, J. Bellmunt, M. Bolla EAU guidelines on prostate cancer Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer Eur Urol 59 2011 572
11. A. Heidenreich, G. Aus, M. Bolla EAU guidelines on prostate cancer Eur Urol 53 2008 68
12. H. Vees, F. Buchegger, S. Albrecht (18)F-choline and/or (11)C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy BJU Int 99 2007 1415
13. G. Giovacchini, M. Picchio, A. Briganti [(11)C]Choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging J Urol 184 2010 938
14. H.I. Scher, M. Eisenberger, A.V. D'Amico Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group J Clin Oncol 22 2004 537
15. P.M. Arlen, F. Bianco, W.L. Dahut Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time J Urol 179 2008 2181
16. E.S. Antonarakis, Y. Chen, S.I. Elsamanoudi Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database BJU Int 108 2010 378
17. S.H. Taylor, K.W. Merriman, P.E. Spiess Inadequacies of the current American Joint Committee on Cancer staging system for prostate cancer Cancer 106 2006 559
18. C.R. Pound, A.W. Partin, M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591
19. Z.A. Dotan, F.J. Bianco Jr, F. Rabbani Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy J Clin Oncol 23 2005 1962
20. P. Zhou, M.H. Chen, D. McLeod Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy J Clin Oncol 23 2005 6992
21. S.J. Freedland, E.B. Humphreys, L.A. Mangold Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy JAMA 294 2005 433
22. M. Souvatzoglou, B.J. Krause, A. Purschel Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer Radiother Oncol 99 2011 193
23. H.A. Vargas, C. Wassberg, O. Akin MR imaging of treated prostate cancer Radiology 262 2012 26
24. V. Panebianco, A. Sciarra, D. Lisi Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP) Eur J Radiol 81 2012 700
25. S.N. Reske, N.M. Blumstein, G. Glatting [(11)C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy Eur J Nucl Med Mol Imaging 35 2008 9
26. V. Scattoni, M. Picchio, N. Suardi Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy Eur Urol 52 2007 423
27. P. Rigatti, N. Suardi, A. Briganti Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography Eur Urol 60 2011 935
28. L. Rinnab, F.M. Mottaghy, J. Simon [11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer Preliminary results of a prospective study Urol Int 81 2008 191